During the past decade, Kliptown Soweto CRS conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kliptown Soweto CRS" #1 sponsor was "COVID-19 Prevention Network" with 2 trials, followed by "HIV Vaccine Trials Network" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "Wits Health Consortium (Pty) Ltd" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliptown Soweto CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Bio Analytical Research Corporation" with 2 trials as a collaborator, "BioVac" with 2 trials as a collaborator, "Biocair" with 2 trials as a collaborator and "Clinical Laboratory Services" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Kliptown Soweto CRS" are "COVID-19" (3 trials), "HIV Infections" (3 trials), "SARS-CoV-2" (2 trials), "HIV Infection" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "Kliptown Soweto CRS" in a lesser frequency.

Most popular intervention types in "Kliptown Soweto CRS" are "Biological" (7 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Sample collection" (2 trials), "ALVAC-HIV (vCP2438)" (1 trials), "Ad26.COV2.S" (1 trials) and "Ad26.Mos4.HIV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliptown Soweto CRS" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kliptown Soweto CRS". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kliptown Soweto CRS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kliptown Soweto CRS, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".